$AMRS News
Last published 1y ago
- 1y agoAMRSDOD Releases Final Nine Awards for Distributed Bioindustrial Manufacturing ProgramU.S. Department of WarThe Department of Defense today announced the remaining nine awards to bioindustrial firms under the Distributed Bioindustrial Manufacturing Program (DBIMP). This announcement completes the first phase of DBIMP investment at 34 total awards worth over $60 million. The awardees include Amyris, based in Emeryville, California; Cauldron Molecules, based in in Australia and the United States; Checkers ...
- 2y agoRCELAMRSAVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate SecretaryGlobeNewswireVALENCIA, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin
- 3y agoAMRSAMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATIONPR NewswireVoluntary Chapter 11 Commenced to Finalize Consensual Go-Forward Plan for Amyris' Core Business $190 Million Financing Commitment from Foris Ventures to Support Day-to-Day Operations EMERYVILLE, Calif., Aug. 9, 2023
- 3y agoAMRSAMYRIS ANNOUNCES CEO TRANSITION AND GLOBAL REDUCTION IN FORCEPR NewswireEMERYVILLE, Calif., June 26, 2023 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™
- 3y agoAMRSAMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDINGPR NewswireEMERYVILLE, Calif., June 5, 2023 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM
- 3y agoAMRSAMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENEPR NewswireEMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology
- 3y agoAMRSAmyris, Inc. (AMRS) Q1 2023 Earnings Call TranscriptEarnings Call Transcripts
- 3y agoAMRSAMYRIS, INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTSPR NewswireCore revenue of $56.1 million exceeded Q1 guidance of $49.9 millionCash operating expense down 4% compared to Q1 2022 and down 24% versus Q4 2022Completed strategic partnership with Givaudan on April 3 for $200 million
- 3y agoAMRSAMYRIS TO HOST FIRST QUARTER 2023 FINANCIAL RESULTS CONFERENCE CALL ON MAY 9PR NewswireEMERYVILLE, Calif., May 2, 2023 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™
- 3y agoAMRSAMYRIS REPORTS Q1 2023 REVENUEPR NewswireEMERYVILLE, Calif., April 24, 2023 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its
- 3y agoAMRSAMYRIS CLOSES STRATEGIC TRANSACTION WITH GIVAUDANPR NewswireLeveraging Amyris' industry-leading biotechnology platform in Beauty for the development and supply of clean sustainable ingredients EMERYVILLE, Calif., April 5, 2023 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a
- 3y agoAMRSAMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTSPR NewswireFourth quarter Consumer revenue of $52.8 million increased 64% over the prior year and was another record quarter. Core revenue of $75.8 million grew 17% over the prior yearFull year Consumer revenue of $176.9 million
- 3y agoAMRSThe Swell & Stripes Announce Menopause Symposium in CaliforniaPR NewswireLOS ANGELES, Feb. 28, 2023 /PRNewswire/ -- Alisa Volkman, Co-founder & CEO of The Swell, and Naomi Watts, Founder & CCO of Stripes, have announced a West Coast-based symposium, The New Pause, following the
- 3y agoAMRSAMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 15, 2023PR NewswireEMERYVILLE, Calif., Feb. 28, 2023 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its
- 3y agoAMRSGIVAUDAN TO ACQUIRE PORTFOLIO OF MAJOR COSMETIC INGREDIENTS FROM AMYRIS AND TO ESTABLISH STRATEGIC PARTNERSHIP FOR NATURAL, SUSTAINABLY SOURCED INGREDIENTS FOR THE BEAUTY INDUSTRYPR NewswireThe bio-based sustainable blockbuster ingredients Squalane, Hemisqualane and Cleanscreen as well as development of future cosmetic ingredients from Amyris will accelerate both companies' leadership in
- 3y agoAMRSAMYRIS LAUNCHES 4U BY TIA™ HAIRCARE LINE EXCLUSIVELY AT WALMARTPR NewswireEMERYVILLE, Calif., Jan. 30, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its
- 3y agoAMRSAMYRIS TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTH CARE CONFERENCEPR NewswireEMERYVILLE, Calif., Jan. 4, 2023 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its
- 3y agoAMRSAMYRIS ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENTPR NewswireEMERYVILLE, Calif., Dec. 29, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its
- 3y agoAMRSAMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTIONPR NewswireEMERYVILLE, Calif., Dec. 27, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM
- 3y agoAMRSAMYRIS CONSUMER BRANDS DELIVER 80% CYBER MONDAY LIKE-FOR-LIKE GROWTHPR NewswireEMERYVILLE, Calif., Nov. 30, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM
- 3y agoAMRSAMYRIS CONSUMER BRANDS DELIVER RECORD BLACK FRIDAY WEEK SALESPR NewswireEMERYVILLE, Calif., Nov. 28, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its
- 4y agoAMRSAMYRIS, INC. REPORTS THIRD QUARTER 2022 FINANCIAL RESULTSPR NewswireSixth consecutive quarter of record consumer revenue – Consumer revenue of $46.6 million increased 98% compared to Q3 2021Record core revenue of $71.1 million grew 49% compared to the prior year quarter"Fit to
- 4y agoAMRSAMYRIS TO HOST THIRD QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON NOVEMBER 8PR NewswireEMERYVILLE, Calif., Nov. 1, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM
- 4y agoAMRSAmyris and World Wildlife Fund Announce Partnership to Protect BiodiversityPR NewswireEMERYVILLE, Calif., Oct. 25, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its
- 4y agoAMRSAMYRIS SUCCESSFULLY LAUNCHES TWO NEW CONSUMER BRANDSPR NewswireEMERYVILLE, Calif., Oct. 24, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™
- 4y agoAMRSAmyris Brands Expanding in UK and Europe. Executing on continued accelerated growth and lower costsPR NewswireEMERYVILLE, Calif., Oct. 11, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its
- 4y agoAMRSAMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCESPR NewswireEMERYVILLE, Calif., Sept. 7, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty cons
- 4y agoAMRSAMYRIS PUBLISHES SECOND ANNUAL ESG REPORTPR NewswireEMERYVILLE, Calif., Aug. 31, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform and clean beauty consum
- 4y agoAMRSIFFSCHWCCXI+6Cramer's lightning round: Charles Schwab is terrificCNBC"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
- 4y agoAMRSAMYRIS, INC. REPORTS SECOND QUARTER 2022 FINANCIAL RESULTSPR NewswireRecord consumer revenue of $43 million increased 108% compared to Q2 2021 Ingredients sold out in first half with $15 million backlog to be supplied in H2 Cost actions and price increases to deliver $50 million of EBITDA improvements in H2 $700 milli
- 4y agoAMRSAmyris (AMRS) Q2 2022 Earnings Call TranscriptEarnings Call TranscriptsAMRS earnings call for the period ending June 30, 2022.
- 4y agoAMRSAMYRIS TO PARTICIPATE AT THE UBS GENOMICS 2.0 AND MEDTECH INNOVATIONS SUMMITPR NewswireEMERYVILLE, Calif., Aug. 3, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that m
- 4y agoAMRSAMYRIS TO HOST SECOND QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 9PR NewswireEMERYVILLE, Calif., July 28, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that
- 4y agoAMRSAVOBYNDDNA+9EATV, the World's First Plant-based Innovation ETF, Makes History at The New York Stock Exchange (NYSE: EATV)PR NewswireVegTech™ Invest, Advisor to EATV, the VegTech™ Plant-based Innovation & Climate ETF, throws historic party at The New York Stock Exchange celebrating the EATV listing and world's first Plant-based Innovation ETF, (NYSE:EAT). LOS ANGELES, June 27
- 4y agoAMRSAMYRIS BARRA BONITA FERMENTATION PLANT BEGINS INDUSTRIAL PRODUCTIONPR NewswireEMERYVILLE, Calif., June 23, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that
- 4y agoAMRSBYNDOTLYPBIO+1Global Plant Based Protein Market Expected To Reach $40 Billion by 2027PR NewswirePALM BEACH, Fla., June 14, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - The pandemic has considerably transformed consumer buying patterns, with a steady shift being witnessed toward health-improving products. People are buying supp
- 4y agoAMRSAMYRIS TO PARTICIPATE AT THE OPPENHEIMER 22nd ANNUAL CONSUMER CONFERENCEPR NewswireEMERYVILLE, Calif., June 7, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that
- 4y agoAMRSAMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022PR NewswireEMERYVILLE, Calif., May 23, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that m
- 4y agoAMRSAMYRIS TO PARTICIPATE AT MAY INVESTOR CONFERENCESPR NewswireEMERYVILLE, Calif., May 23, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform, today announced that ma
- 4y agoAMRSPLUGRDBXVRM+1Thinking about buying stock in Exicure, Vroom, Redbox, Amyris, or Plug Power?PR NewswireNEW YORK, May 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XCUR, VRM, RDBX, AMRS, and PLUG. T
- 4y agoAMRSAMYRIS, INC. REPORTS FIRST QUARTER 2022 FINANCIAL RESULTSPR NewswireRecord consumer revenue of $34.6 million increased 121% compared to Q1 2021 Barra Bonita commissioning on track to commence ingredients production in Q2 EMERYVILLE, Calif., May 10, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic
- 4y agoAMRSAmyris (AMRS) Q1 2022 Earnings Call TranscriptEarnings Call TranscriptsAMRS earnings call for the period ending March 31, 2022.
- 4y agoAMRSAMYRIS TO HOST FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON MAY 10PR NewswireEMERYVILLE, Calif., May 3, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it
- 4y agoAMRSAMYRIS HOSTS SUCCESSFUL INVESTOR EVENTPR NewswireEMERYVILLE, Calif., April 14, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, successfully hosted
- 4y agoAMRSAMYRIS STARTS COMMISSIONING OF INDUSTRY LEADING FERMENTATION PLANTPR NewswireEMERYVILLE, Calif., April 11, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that
- 4y agoAMRSBYNDCELHCOCO+7VegTech™ Invest Launches the VegTech™ Plant-based Innovation & Alternative Proteins IndexPR NewswireCalculated and Distributed by Morningstar Indexes, the Index Defines and Leads a New Global Investment Category in Capital Markets LOS ANGELES, March 29, 2022 /PRNewswire/ -- VegTech™ Invest, advisor to the active VegTech™ Plant-based Innovation &
- 4y agoAMRSAMYRIS TO PARTICIPATE IN THE JEFFERIES VIRTUAL SYNTHETIC BIOLOGY WEEKPR NewswireEMERYVILLE, Calif., March 17, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that
- 4y agoAMRSAMYRIS CLOSES ACQUISITION OF MENOLABSPR NewswireEMERYVILLE, Calif., March 11, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced tha
- 4y agoAMRSAMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTSPR NewswireEMERYVILLE, Calif., March 1, 2022 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform, today announced finan
- 4y agoAMRSAmyris (AMRS) Q4 2021 Earnings Call TranscriptEarnings Call TranscriptsAMRS earnings call for the period ending December 31, 2021.